Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Opin Hematol. 2000 Nov;7(6):397-401.

Universal leukocyte reduction.

Author information

  • 1Sacramento Medical Foundation Blood Center, California 95816-7089, USA. patricia.kopko@smfbc.org

Abstract

Leukocyte reduction of blood components, in the United States, is generally reserved for conditions in which a clinical indication has been documented. There is no evidence that either Creutzfeldt-Jakob disease or variant Creutzfeldt-Jakob disease are transmitted by transfusion in humans or that leukocyte reduction of blood components could reduce their transmission. A number of adverse outcomes following transfusion are alleged to be the result of white blood cells. At this point in time, there are insufficient clinical data to justify the universal leukocyte reduction of blood components.

PMID:
11055514
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk